✉news BusinessStartups first seen 2 h ago, last 53 min ago, peak #2
Novartis signs $7.8 billion drug deal with Chinese startup
Swiss pharmaceutical giant Novartis has signed a deal worth $7.8 billion with a Chinese startup, according to Axios. The agreement is a major licensing or partnership arrangement centered on drug development, underscoring Novartis's push to tap into China's fast-growing biotech sector. It ranks among the larger cross-border pharma deals involving a young Chinese company.
Why now: The sheer size of the deal and growing Western pharma interest in Chinese biotech innovation make it major industry news.
Rank over time, top of the chart is #1. 2 snapshots from 2 h ago to 53 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/756333